novel class of antibiotics
Topical treatment
systemic antibiotics
current leading topical antibiotics
leading topical antibiotics ineffective
marketed antibiotics
chemical class of compounds
compound class benefits
effective topical alternative
label use of topical
treatment of infected atopic dermatitis
novo resistance
antibiotic resistance
current resistance problems
systemic treatments
particular ATx201 benefits
favourable resistance evolution properties
systemic indications
alternative treatments
physicians
significant unmet medical need AntibioTx
chemical scaffold
dermatological infections
bacterial infections
significant comorbidity
result patients
antibacterial properties
vancomycin resistant enterococci
methicillin resistant Staphylococcus aureus
decades of safe oral use
innovative solution
MRSA
proven human safety profile
wide spectrum of effect
substantial competitive advantages
broad applicability
disease
non-bacterial purposes
lead candidate
thel approach
onset
potential
strong ability
patent
time